Drugs / Calcium Citrate with Vitamin D2
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03621553 Background | Jul 2010 → Dec 2026 expected | sarcoidosis, vitamin D deficiency | University of Texas Southwestern Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcium Citrate with Vitamin D2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03621553 ↗ |
| Route | Oral | “will be given by mouth for 24 weeks.” NCT03621553 ↗ |